Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Bo Didley who wrote (2156)	2/1/2000 5:43:00 PM
From: Bo Didley	Respond to of 5582

1st Quarter Production and Sales Now that Q4 is out, lets get ready for Q1: Production Capacity: raised to 70k/day times 5 days = 350k units/week 350k units x 13 weeks = 4,550,000 units 4,550,000 units x $7 (zicam wholesale) = $31,850,000 if production translated into sales. Yes, $31 Million Sales Q1 would be the top. Look for them to find other manufacturers to increase production when they start shipping internationally. GUMM is reminding me of what happened to KIDE beginning last February after its earnings were released and positive for the first time. It will start to get noticed as a super growth company and the price will continually trend higher and higher and even higher when subsequant earnings show even more growth. bo